Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial
about
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tropomyosin Receptor Antagonis ...... a randomised controlled trial
@en
Tropomyosin Receptor Antagonis ...... a randomised controlled trial.
@nl
type
label
Tropomyosin Receptor Antagonis ...... a randomised controlled trial
@en
Tropomyosin Receptor Antagonis ...... a randomised controlled trial.
@nl
prefLabel
Tropomyosin Receptor Antagonis ...... a randomised controlled trial
@en
Tropomyosin Receptor Antagonis ...... a randomised controlled trial.
@nl
P2093
P2860
P50
P1433
P1476
Tropomyosin Receptor Antagonis ...... a randomised controlled trial
@en
P2093
Amy Cranston
David Roblin
Deborah D Stocken
Elaine Stamp
James Langtry
Julia Hamlin
Ruth Plummer
P2860
P2888
P356
10.1186/S13063-017-1812-Z
P577
2017-03-07T00:00:00Z
P6179
1084252064